Advances painted in shades of gray at a D.C. conference.
Cohen
J
J
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000401:mortality / Q000821:virology; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects / Q000302:isolation & purification; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019562:Viral Load; D014766:Viremia / Q000188:drug therapy
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors